Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...

April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for ...

A federal prescription drug discount program meant to support underserved patients has been leveraged by large hospitals to ...

AbbVie sues HHS over 340B patient definition to tighten eligibility and prevent duplicate discounts in federal drug pricing ...

Catholic healthcare was not started nor inspired from profit and loss statements or a desire to drive more shareholder value. Instead, through acts of mercy, women religious crossed oceans on ...

Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.

Both drugmakers filed complaints in the U.S. District Court for the Western District of Washington and asked judges for an ...

Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...

The 340B drug discount program would work better if the money followed the patient rather than going directly to hospitals, Anthony DiGiorgio, DO, MHA, said Monday at an event on 340B sponsored by the ...

Ravin Consultants announced today a leadership evolution that reflects the strength of its foundation and its long-term vision for the future of the 340B program. This press release features ...